<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=2302185" created="06/11/19" creator="Yumiko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>2302185</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Characterization of the <term id="T1" lex="human_immunodeficiency_virus_type_1_enhancer-binding_protein" sem="Protein_family_or_group"><term id="T2" lex="human_immunodeficiency_virus_type_1_enhancer" sem="DNA_domain_or_region"><term id="T3" lex="human_immunodeficiency_virus" sem="Virus">human immunodeficiency virus</term> type 1 enhancer</term>-binding proteins</term> from the <term id="T4" lex="human_T-cell_line" sem="Cell_cultured">human T-cell line</term> <term id="T5" lex="Jurkat" sem="Cell_cultured">Jurkat</term>.</sentence>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The transcription of the <term id="T6" lex="human_immunodeficiency_virus_type_1" sem="Virus"><term id="T7" lex="human_immunodeficiency_virus" sem="Virus">human immunodeficiency virus</term> type 1</term> (<term id="T8" lex="HIV-1" sem="Virus">HIV-1</term>) is under the control of <term id="T9" lex="cellular_protein" sem="Protein_family_or_group">cellular proteins</term> that bind to the <term id="T10" lex="viral_long_terminal_repeat" sem="DNA_domain_or_region">viral long terminal repeat</term> (<term id="T11" lex="LTR" sem="DNA_domain_or_region">LTR</term>).</sentence>
<event KT="Other" id="E1">
<type class="Transcription"/>
<theme idref="T8"/>
<clue>The <clueType>transcription</clueType> <linkTheme>of</linkTheme> the human immunodeficiency virus type 1 (HIV-1) is under the control of cellular proteins that bind to the viral long terminal repeat (LTR).</clue>
</event>
<event KT="Other" id="E2">
<type class="Binding"/>
<theme idref="T9"/>
<theme idref="T11"/>
<clue>The transcription of the human immunodeficiency virus type 1 (HIV-1) is under the control of cellular proteins that <clueType>bind</clueType> <linkTheme>to</linkTheme> the viral long terminal repeat (LTR).</clue>
</event>
<event KT="Fact" id="E3">
<type class="Regulation"/>
<theme idref="E1"/>
<cause idref="T9"/>
<clue>The transcription of the human immunodeficiency virus type 1 (HIV-1) is under the <clueType>control</clueType> <linkCause>of</linkCause> cellular proteins that bind to the viral long terminal repeat (LTR).</clue>
</event>
<sentence id="S3">Among the protein-binding regions of the <term id="T12" lex="HIV-1_LTR" sem="DNA_domain_or_region">HIV-1 LTR</term> is the <term id="T13" lex="transcription-enhancer_region" sem="DNA_domain_or_region">transcription-enhancer region</term>.</sentence>
<sentence id="S4">We show that at least one <term id="T14" lex="inducible_protein" sem="Protein_family_or_group">inducible</term>, <term id="T15" lex="C1" sem="Protein_molecule">C1</term>, and one <term id="T16" lex="constitutive,_C2,_protein" sem="Protein_molecule">constitutive, <term id="T17" lex="C2" sem="Protein_molecule">C2</term>, <term id="A100" sem="Protein_molecule">protein</term></term> can bind to the <term id="T18" lex="HIV_enhancer" sem="DNA_domain_or_region">HIV enhancer</term> in <term id="T19" lex="Jurkat_cell" sem="Cell_cultured">Jurkat cells</term>.</sentence>
<event CL="L2" KT="Analysis" id="E4">
<type class="Binding"/>
<theme idref="T18"/>
<theme idref="T15" idref1="A100"/>
<clue>We <clueKT>show</clueKT> that at least one inducible, C1, and one constitutive, C2, protein <clueCL>can</clueCL> <clueType>bind</clueType> <linkTheme>to</linkTheme> the HIV enhancer <clueLoc>in Jurkat cells</clueLoc>.</clue>
</event>
<event CL="L2" KT="Analysis" id="E5">
<type class="Binding"/>
<theme idref="T18"/>
<theme idref="T17" idref1="A100"/>
<clue>We <clueKT>show</clueKT> that at least one inducible, C1, and one constitutive, C2, protein <clueCL>can</clueCL> <clueType>bind</clueType> <linkTheme>to</linkTheme> the HIV enhancer <clueLoc>in Jurkat cells</clueLoc>.</clue>
</event>
<sentence id="S5">The two proteins differ in their <term id="T20" lex="surface_charge" sem="Other">surface charge</term>, since they are separable by <term id="T21" lex="anion-exchange_chromatography" sem="Other">anion-exchange chromatography</term>.</sentence>
<sentence id="S6"><term id="T22" lex="Bivalent_cations" sem="Element">Bivalent cations</term> such as <term id="T23" lex="Mg2+" sem="Element">Mg2+</term> and <term id="T24" lex="Zn2+" sem="Element">Zn2+</term> differentially affect their binding to <term id="A109" sem="Polynucleotide"><term id="T25" lex="oligonucleotide" sem="Polynucleotide">oligonucleotides</term> which contain the <term id="T26" lex="HIV-enhancer_domain" sem="DNA_domain_or_region">HIV-enhancer domain</term></term>.</sentence>
<event id="E6">
<type class="Binding"/>
<theme idref="T15" idref1="A100"/>
<theme idref="A109"/>
<clue>Bivalent cations such as Mg2+ and Zn2+ differentially affect <corefTheme idref1="T15" idref2="A100">their</corefTheme> <clueType>binding</clueType> <linkTheme>to</linkTheme> oligonucleotides which contain the HIV-enhancer domain.</clue>
<comment>OK</comment></event>
<event id="E7">
<type class="Binding"/>
<theme idref="T17" idref1="A100"/>
<theme idref="A109"/>
<clue>Bivalent cations such as Mg2+ and Zn2+ differentially affect <corefTheme idref1="T17" idref2="A100">their</corefTheme> <clueType>binding</clueType> <linkTheme>to</linkTheme> oligonucleotides which contain the HIV-enhancer domain.</clue>
<comment>OK</comment></event>
<event id="E8">
<type class="Regulation"/>
<theme idref="E6"/>
<cause idref="T23"/>
<clue><corefCause>Bivalent cations</corefCause> such as Mg2+ and Zn2+ differentially <clueType>affect</clueType> their binding to oligonucleotides which contain the HIV-enhancer domain.</clue>
<comment>TPS A109</comment></event>
<event id="E9">
<type class="Regulation"/>
<theme idref="E6"/>
<cause idref="T24"/>
<clue><corefCause>Bivalent cations</corefCause> such as Mg2+ and Zn2+ differentially <clueType>affect</clueType> their binding to oligonucleotides which contain the HIV-enhancer domain.</clue>
</event>
<event id="E10">
<type class="Regulation"/>
<theme idref="E7"/>
<cause idref="T23"/>
<clue><corefCause>Bivalent cations</corefCause> such as Mg2+ and Zn2+ differentially <clueType>affect</clueType> their binding to oligonucleotides which contain the HIV-enhancer domain.</clue>
</event>
<event id="E11">
<type class="Regulation"/>
<theme idref="E7"/>
<cause idref="T24"/>
<clue><corefCause>Bivalent cations</corefCause> such as Mg2+ and Zn2+ differentially <clueType>affect</clueType> their binding to oligonucleotides which contain the HIV-enhancer domain.</clue>
</event>
<sentence id="S7">Both <term id="T27" lex="C1" sem="Protein_molecule">C1</term> and <term id="T28" lex="C2_protein" sem="Protein_molecule">C2 <term id="A1" sem="Protein_molecule">proteins</term></term> also bind to a similar sequence found in the <term id="T29" lex="interleukin-2-receptor_alpha-subunit_enhancer" sem="DNA_domain_or_region"><term id="T30" lex="interleukin-2-receptor_alpha-subunit" sem="Protein_molecule"><term id="T31" lex="interleukin-2" sem="Protein_molecule">interleukin-2</term>-receptor alpha-subunit</term> enhancer</term>.</sentence>
<event id="E12">
<type class="Binding"/>
<theme idref="T27" idref1="A1"/>
<theme idref="T29"/>
<clue>Both C1 and C2 proteins also <clueType>bind</clueType> <linkTheme>to</linkTheme> a similar sequence found in the interleukin-2-receptor alpha-subunit enhancer.</clue>
</event>
<event id="E13">
<type class="Binding"/>
<theme idref="T28"/>
<theme idref="T29"/>
<clue>Both C1 and C2 proteins also <clueType>bind</clueType> <linkTheme>to</linkTheme> a similar sequence found in the interleukin-2-receptor alpha-subunit enhancer.</clue>
</event>
<sentence id="S8">The <term id="T32" lex="inducible_C1_protein" sem="Protein_molecule">inducible <term id="T33" lex="C1" sem="Protein_molecule">C1</term> protein</term> was partially purified by three <term id="T34" lex="chromatographic_step" sem="Other">chromatographic steps</term> and characterized by <term id="T35" lex="u.v._cross-linking" sem="Other">u.v. cross-linking</term> as a <term id="T36" lex="47_kDa_protein" sem="Protein_molecule">47 kDa protein</term>.</sentence>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
